Evaluating the Impact of Programmatic Mass Drug Administration for Malaria in Zambia Using Routine Incidence Data

Journal of Infectious Diseases

Volumn 225, Issue 8, 2022, Pages 1415-1423

  Fraser, Maya ^a   Miller, John M ^b   Silumbe, Kafula ^b   Hainsworth, Michael ^a   Mudenda, Mutinta ^c   Hamainza, Busiku ^c   Moonga, Hawela ^c   Kawesha, Elizabeth Chizema ^c   Mercer, Laina D ^a   Bennett, Adam ^a,e   Schneider, Kammerle ^a   Slater, Hannah C ^a   Eisele, Thomas P ^d   Guinovart, Caterina ^a,f  

^a PATH   (United States)

^b PATH MACEPA   (Zambia)

^c MINISTRY OF HEALTH   (Zambia)

^d TULANE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

Author keywords

impact evaluation; malaria; mass drug administration; routine data

Indexed keywords

ARTEMETHER; ARTEMISININ; DIHYDROARTEMISININ; PIPERAQUINE; ANTIMALARIAL AGENT;

ADULT; BLOOD SMEAR; CATCHMENT AREA; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH CARE FACILITY; HOSPITALIZATION; HUMAN; INCIDENCE; INDOOR RESIDUAL SPRAYING; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; MASS DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; PREVALENCE; SEASON; SEASONAL VARIATION; TIME SERIES ANALYSIS; VACCINATION; VECTOR CONTROL; ZAMBIA;

ANTIMALARIALS; HUMANS; INCIDENCE; MALARIA; MASS DRUG ADMINISTRATION; ZAMBIA;

EID: 85107693313     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiaa434     Document Type: Conference Paper

References (22)

1. World Health Organization. World malaria report 2018. Available at: http://www. who. int/malaria/publications/ world-malaria-report-2018/report/en/. Accessed 29 July 2019.
2. Eisele TP. Mass drug administration can be a valuable addition to the malaria elimination toolbox. Malar J 2019; 18:281.
3. Guidelines for the Treatment of Malaria. 2nd ed. Geneva, Switzerland: World Health Organization; 2010.
4. Newby G, Hwang J, Koita K, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg 2015; 93:125-34.
5. World Health Organization. Recommendations on the role of mass drug administration, mass screening and treatment, and focal screening and treatment for malaria. Available at: http://www. who. int/malaria/publications/atoz/role-ofmda-for-malaria/en/. Accessed 9 July 2019.
6. Eisele TP, Bennett A, Silumbe K, et al. Short-term impact of mass drug administration with dihydroartemisinin plus piperaquine on Malaria in Southern Province Zambia: a cluster-randomized controlled trial. J Infect Dis 2016; 214:1831-9.
7. Government of the Republic of Zambia, Ministry of Health. Zambia National Malaria Indicator Survey 2015. Available at: http://www. makingmalariahistory. org/wp-content/uploads/ 2017/06/Zambia-MIS2015_Jan20-nosigs. pdf. Accessed 22 January 2019.
8. National Malaria Elimination Center. Zambia national malaria elimination strategic plan 2017. Available at: https:// static1. squarespace. com/static/58d002f017bffcf99fe21889/ t/5b28d7f1575d1ff0942dbce1/1529403401067/National+ Malaria+Elimination+Strategic+Plan+2017-Final_PRINT. pdf. Accessed 1 April 2019.
9. USGS FEWS NET Data Portal. Available at: https:// earlywarning. usgs. gov/fews/search/Africa/Southern%20 Africa. Accessed 9 July 2018.
10. Wan Z, University of California Santa Barbara, Simon Hook, Glynn Hulley-JPL and MODAPS SIPS-NASA. MOD11A1 MODIS/Terra Land Surface Temperature and the Emissivity Daily L3 Global 1km SIN Grid. NASA LP DAAC, 2015. doi:10. 5067/MODIS/MOD11A1. 006
11. Bhatt S, Weiss D, Mappin B, et al. Coverage and system efficiencies of insecticide-treated nets in Africa from 2000 to 2017. eLife Sci 2015; 4:e09672.
12. Linden A. Conducting interrupted time-series analysis for single-and multiple-group comparisons. Stata J 2015; 15:480-500.
13. Ashton RA, Bennett A, Yukich J, Bhattarai A, Keating J, Eisele TP. Methodological considerations for use of routine health information system data to evaluate malaria program impact in an era of declining malaria transmission. Am J Trop Med Hyg 2017; 97:46-57.
14. Eisele TP, Bennett A, Silumbe K, et al. Impact of 4 rounds of mass drug administration with dihydroartemisininpiperaquine implemented in Southern Province, Zambia. Am J Trop Med Hyg 2020. doi:10. 4269/ajtmh. 19-0659
15. Keating GM. Dihydroartemisinin/piperaquine. Drugs 2012; 72:937-61.
16. Landier J, Kajeechiwa L, Thwin MM, et al. Safety and effectiveness of mass drug administration to accelerate elimination of artemisinin-resistant falciparum malaria: a pilot trial in four villages of Eastern Myanmar. Wellcome Open Res 2017; 2:81.
17. Pongvongsa T, Phommasone K, Adhikari B, et al. The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin-piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos. Malar J 2018; 17:405.
18. Tripura R, Peto TJ, Chea N, et al. A controlled trial of mass drug administration to interrupt transmission of multidrugresistant falciparum malaria in Cambodian Villages. Clin Infect Dis 2018; 67:817-26.
19. Dengela D, Seyoum A, Lucas B, et al. Multi-country assessment of residual bio-efficacy of insecticides used for indoor residual spraying in malaria control on different surface types: results from program monitoring in 17 PMI/USAIDsupported IRS countries. Parasit Vectors 2018; 11:71.
20. Porter TR, Finn TP, Silumbe K, et al. Recent travel history and Plasmodium falciparum malaria infection in a region of heterogenous transmission in Southern Province, Zambia. Am J Trop Med Hyg 2020. doi:10. 4269/ ajtmh. 19-0660
21. Morris U, Msellem MI, Mkali H, et al. A cluster randomised controlled trial of two rounds of mass drug administration in Zanzibar, a malaria pre-elimination setting-high coverage and safety, but no significant impact on transmission. BMC Med 2018; 16:215.
22. Aregawi M, Smith SJ, Sillah-Kanu M, et al. Impact of the mass drug administration for malaria in response to the Ebola outbreak in Sierra Leone. Malar J 2016; 15:480.